References

1.        Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4(1):14.

2.        Chen Y-Y, Hu H-Y, Chu D, Chen H-H, Chang C-K, Chou P. Patients with Primary Open-Angle Glaucoma May Develop Ischemic Heart Disease More Often than Those without Glaucoma: An 11-Year Population-Based Cohort Study. PLoS One. 2016;11(9):e0163210.

3.        Escalona-Rojas  josé enrique munoz de, Cantero-Hinojosa J, Garrido-Pareja F, Padilla-torres F, Garcı L. Componente hemodinámico en el glaucoma y su asocciación con factores de riesgo y enfermedades cardiovasculares. Med Clin (Barc). 2013; 143(4):157-60.

4.        Mewman-Casey PA, Talwar N, Nan B, Musch DC, Stein JD. The relationship Between Components of Metabolic Syndrome and Open-Angle Glaucoma. Clin Exp Ophthalmol. 2012;118(7):1318–26.

5.        Zhao Y, Chen X. Meta-analysis of prospective cohort studies. J Ophthalmol. 2017;10(9):1430–5.

6.        Barthelmes J, Nägele MP, Ludovici V, Ruschitzka F, Sudano I, Flammer AJ. Endothelial dysfunction in cardiovascular disease and Flammer syndrome—similarities and differences. EPMA J. 2017;8(2):99–109.

7.        Kawasaki R, Wang JJ, Rochtchina E, Lee AJ, Wong TY, Mitchell P. Retinal Vessel Caliber Is Associated with the 10-year Incidence of Glaucoma. The Blue Mountais Eye Study. Ophthalmology; 2013;120(1):84–90.

8.        Lee EJ, Lee SH, Kim JA, Kim TW. Parapapillary deep-layer microvasculature dropout in glaucoma: Topographic association with glaucomatous damage. Investig Ophthalmol Vis Sci. 2017;58(7):3004–10.

9.        Yanagi M, Kawasaki R, Jin J, Mmed W, Wong TY. Review Vascular risk factors in glaucoma : a review. Clin Exp Ophthalmol. 2011: 252–8.

10.      Grieshaber MC, Mozaffarieh M, Flammer J. What Is the Link Between Vascular Dysregulation and Glaucoma? Surv Ophthalmol. 2007; 52:144–54.

11.      Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, et al. Flammer syndrome. EPMA J. 2014;5(1):11.

12.      Abegão Pinto L, Willekens K, Van Keer K, Shibesh A, Molenberghs G, Vandewalle E, et al. Ocular blood flow in glaucoma - the Leuven Eye Study. Acta Ophthalmol. 2016;94(6):592–8.

13.      Abegão Pinto L, Vandewalle E, Willekens K, Marques-Neves C, Stalmans I. Ocular pulse amplitude and Doppler waveform analysis in glaucoma patients. Acta Ophthalmol. 2014;92(4):280–5.

14.      Konieczka K, Choi HJ, Koch S, Fankhauser F, Schoetzau A, Kim DM. Relationship between normal tension glaucoma and Flammer syndrome. EPMA J. 2017;8(2):111–7.

15.      Konieczka K, Todorova MG, Bojinova RI, Binggeli T, Chackathayil TN, Flammer J. Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome. Klin Monbl Augenheilkd. 2016;233(4):387–90.

16.      Fan N, Wang P, Tang L, Liu X. Ocular Blood Flow and Normal Tension Glaucoma. Biomed Res Int. 2015; 2015:308505  

17.      Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol. Elsevier; 2013;13(1):43–9.

18.      Vahedian Z, Fakhraie G, Bovet J, Mozaffarieh M. Nutritional recommendations for individuals with Flammer syndrome. EPMA J. EPMA Journal; 2017;8(2):187–95.

19.      Quaranta L, Bettelli S, Uv MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on visual field progression in normal tension glaucoma. J Glaucoma. 2013;22(9):780–4.

20.      Mozaffarieh M, Flammer J. Is There More to Glaucoma Treatment Than Lowering IOP ? Surv Ophthalmol. 2007;52(November):174–9.

21.      Ohguro I, Ohguro H. The Effects of a Fixed Combination of 0.5% Timolol and 1% Dorzolamide on Optic Nerve Head Blood Circulation. J Ocul Pharmacol Ther. 2012;28(4):392–6.

22.      Chandra S, Muir ER, Deo K, Kiel JW, Duong TQ. Effects of dorzolamide on retinal and choroidal blood flow in the DBA/2J mouse model of glaucoma. Investig Ophthalmol Vis Sci. 2016;57(3):826–31.

4th Edition - May 2017